Quantifying the mental health burden of the most severe covid-19 restrictions: A natural experiment.
Mental health
Population burden
Severe COVID-19 restrictions
Journal
Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073
Informations de publication
Date de publication:
01 10 2021
01 10 2021
Historique:
received:
26
01
2021
revised:
21
06
2021
accepted:
27
06
2021
pubmed:
12
7
2021
medline:
11
8
2021
entrez:
11
7
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic, and the restrictions required to halt spread of the infection, are associated with increased population burden of moderate to severe symptoms of depression and anxiety. The aim was to quantify the mental health burden of the most severe COVID-19 related restrictions. A natural experiment in which differences between Australian states and territories in the severity of restrictions for pandemic control, divided the population. People in Victoria experienced the most severe, and people in all other states and territories less severe or negligible restrictions. Data were collected in national, anonymously completed, online surveys (in April and in July / August 2020) of adults in Australia. Outcomes were, in the previous fortnight, experiencing clinically significant depressive symptoms (Patient Health Questionnaire 9 score ≥10); or symptoms of generalised anxiety (Generalised Anxiety Disorder Scale 7 score ≥10). In total, 23,749 eligible respondents contributed complete data. There were no differences in the population burden of mental health problems between Victoria and the other states and territories at Survey One. By Survey Two prevalence rates of clinically significant depressive (Adjusted Odds Ratio (aOR) 1.96; 95% CI 1.62; 2.37) and anxiety (aOR 1.87; 95%CI 1.53; 2.29) symptoms were substantially and significantly higher in Victoria than in other states and territories. Online surveys are less accessible to some groups of people. The data are self-report and not diagnostic. The most severe COVID-19 restrictions are associated with near double the population prevalence of moderate to severe depressive and generalised anxiety symptoms.
Sections du résumé
BACKGROUND
The COVID-19 pandemic, and the restrictions required to halt spread of the infection, are associated with increased population burden of moderate to severe symptoms of depression and anxiety. The aim was to quantify the mental health burden of the most severe COVID-19 related restrictions.
METHODS
A natural experiment in which differences between Australian states and territories in the severity of restrictions for pandemic control, divided the population. People in Victoria experienced the most severe, and people in all other states and territories less severe or negligible restrictions. Data were collected in national, anonymously completed, online surveys (in April and in July / August 2020) of adults in Australia. Outcomes were, in the previous fortnight, experiencing clinically significant depressive symptoms (Patient Health Questionnaire 9 score ≥10); or symptoms of generalised anxiety (Generalised Anxiety Disorder Scale 7 score ≥10).
RESULTS
In total, 23,749 eligible respondents contributed complete data. There were no differences in the population burden of mental health problems between Victoria and the other states and territories at Survey One. By Survey Two prevalence rates of clinically significant depressive (Adjusted Odds Ratio (aOR) 1.96; 95% CI 1.62; 2.37) and anxiety (aOR 1.87; 95%CI 1.53; 2.29) symptoms were substantially and significantly higher in Victoria than in other states and territories.
LIMITATIONS
Online surveys are less accessible to some groups of people. The data are self-report and not diagnostic.
CONCLUSIONS
The most severe COVID-19 restrictions are associated with near double the population prevalence of moderate to severe depressive and generalised anxiety symptoms.
Identifiants
pubmed: 34246949
pii: S0165-0327(21)00646-7
doi: 10.1016/j.jad.2021.06.060
pmc: PMC8264352
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
406-414Informations de copyright
Copyright © 2021. Published by Elsevier B.V.
Références
Psychiatry Res. 2020 May;287:112921
pubmed: 32240896
Epidemiol Serv Saude. 2020;29(4):e2020427
pubmed: 32844918
J Affect Disord. 2020 Dec 1;277:842-849
pubmed: 33065825
J Affect Disord. 2020 Nov 1;276:30-37
pubmed: 32697713
Cad Saude Publica. 2020 Apr 30;36(4):e00054020
pubmed: 32374806
Brain Behav. 2020 Aug;10(8):e01730
pubmed: 32578943
J Anxiety Disord. 2020 Oct;75:102291
pubmed: 32827869
Psychiatry Res. 2020 Sep;291:113267
pubmed: 32623266
Int J Environ Res Public Health. 2020 Mar 31;17(7):
pubmed: 32244498
J Affect Disord. 2020 Nov 1;276:446-452
pubmed: 32871676
Sleep Med. 2020 Nov;75:12-20
pubmed: 32853913
PLoS One. 2020 Apr 16;15(4):e0231924
pubmed: 32298385
Int J Soc Psychiatry. 2020 Dec;66(8):756-762
pubmed: 32567466
Psychiatry Res. 2020 Nov;293:113396
pubmed: 32861096
Int J Environ Res Public Health. 2020 Sep 17;17(18):
pubmed: 32957702
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
JAMA Netw Open. 2020 Sep 1;3(9):e2019686
pubmed: 32876685
Lancet. 2020 Oct 10;396(10257):1102-1124
pubmed: 32941825
Annu Rev Public Health. 2017 Mar 20;38:39-56
pubmed: 28125392
Int J Environ Health Res. 2022 Apr;32(4):850-861
pubmed: 32741205
Int J Environ Res Public Health. 2020 Sep 14;17(18):
pubmed: 32937929
Psychol Trauma. 2020 Jul;12(5):499-501
pubmed: 32525391
Int J Environ Res Public Health. 2020 Jul 02;17(13):
pubmed: 32630821
Depress Anxiety. 2020 Oct;37(10):954-956
pubmed: 32667081
Med J Aust. 2020 Nov;213(10):458-464
pubmed: 33107063
Psychol Health Med. 2021 Jan;26(1):23-34
pubmed: 32286091
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Psychiatry Res. 2020 Sep;291:113138
pubmed: 32562931
Int J Environ Res Public Health. 2020 Aug 31;17(17):
pubmed: 32877985
Asian J Psychiatr. 2020 Jun;51:102052
pubmed: 32361387
Brain Behav Immun. 2020 Jul;87:172-176
pubmed: 32405150
JAMA Netw Open. 2020 Jul 1;3(7):e2014053
pubmed: 32609353
Front Psychiatry. 2020 Oct 06;11:579985
pubmed: 33132940
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Asian J Psychiatr. 2020 Jun;51:102076
pubmed: 32334409
Lancet Psychiatry. 2020 Oct;7(10):883-892
pubmed: 32707037